ALGN

ALGN
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $995.692M ▼ | $542.903M ▼ | $56.753M ▼ | 5.7% ▼ | $0.78 ▼ | $152.015M ▼ |
| Q2-2025 | $1.012B ▲ | $545.084M ▼ | $124.608M ▲ | 12.308% ▲ | $1.72 ▲ | $203.609M ▲ |
| Q1-2025 | $979.262M ▼ | $549.008M ▼ | $93.23M ▼ | 9.52% ▼ | $1.27 ▼ | $174.426M ▼ |
| Q4-2024 | $995.219M ▲ | $552.792M ▲ | $103.807M ▼ | 10.431% ▼ | $1.39 ▼ | $215.221M ▲ |
| Q3-2024 | $977.872M | $519.476M | $115.963M | 11.859% | $1.55 | $200.157M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.032B ▲ | $6.234B ▲ | $2.276B ▼ | $3.957B ▲ |
| Q2-2025 | $901.157M ▲ | $6.219B ▲ | $2.306B ▼ | $3.913B ▲ |
| Q1-2025 | $873.012M ▼ | $6.103B ▼ | $2.309B ▼ | $3.794B ▼ |
| Q4-2024 | $1.044B ▲ | $6.215B ▼ | $2.363B ▼ | $3.852B ▼ |
| Q3-2024 | $1.042B | $6.366B | $2.422B | $3.944B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.753M ▲ | $188.72M ▲ | $-19.761M ▲ | $-64.119M ▲ | $103.466M ▲ | $122.191M ▼ |
| Q2-2025 | $-93.23M ▼ | $128.65M ▲ | $-31.479M ▼ | $-96.299M ▲ | $28.268M ▲ | $153.939M ▲ |
| Q1-2025 | $93.23M ▼ | $52.676M ▼ | $-25.289M ▲ | $-206.756M ▼ | $-170.889M ▼ | $27.387M ▼ |
| Q4-2024 | $103.807M ▼ | $286.078M ▲ | $-53.916M ▼ | $-203.019M ▼ | $1.982M ▼ | $263.117M ▲ |
| Q3-2024 | $115.963M | $263.662M | $-8.919M | $10.572M | $280.519M | $233.862M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Clear Aligner | $820.00M ▲ | $830.00M ▲ | $790.00M ▼ | $790.00M ▲ |
Scanners And Services | $180.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Align Technology combines a strong, differentiated product platform with solid financial foundations. Revenue and operating profits are growing at a steady, not explosive, pace, underpinned by healthy margins. The balance sheet is conservative, with ample cash and minimal debt, and cash generation is robust enough to fund ongoing investments without relying heavily on external financing. Strategically, Align enjoys a powerful brand, entrenched relationships with dental professionals, and a tightly integrated digital workflow that reinforces customer loyalty. Its innovation engine—spanning materials, software, AI, and 3D printing—supports its leadership in clear aligners and digital dentistry. Key uncertainties include rising competition, pricing pressure, consumer sensitivity to economic conditions, and the need to keep innovating to maintain its technological edge. Overall, Align appears to be a financially sound, innovation‑driven leader in a niche of healthcare that still has room to digitize and expand, but its long‑term trajectory will depend on how well it manages competition and continues to evolve its technology and ecosystem.
NEWS
November 25, 2025 · 7:02 PM UTC
Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction
Read more
November 24, 2025 · 8:00 PM UTC
Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
Read more
November 4, 2025 · 4:01 PM UTC
Align Technology to Speak at Upcoming Financial Conferences
Read more
November 3, 2025 · 4:02 PM UTC
Align Technology Opens 2026 Annual Research Program to Advance Orthodontic and Dental Patient Care
Read more
October 29, 2025 · 4:03 PM UTC
Align Technology Announces Third Quarter 2025 Financial Results
Read more
About Align Technology, Inc.
https://www.aligntech.comAlign Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $995.692M ▼ | $542.903M ▼ | $56.753M ▼ | 5.7% ▼ | $0.78 ▼ | $152.015M ▼ |
| Q2-2025 | $1.012B ▲ | $545.084M ▼ | $124.608M ▲ | 12.308% ▲ | $1.72 ▲ | $203.609M ▲ |
| Q1-2025 | $979.262M ▼ | $549.008M ▼ | $93.23M ▼ | 9.52% ▼ | $1.27 ▼ | $174.426M ▼ |
| Q4-2024 | $995.219M ▲ | $552.792M ▲ | $103.807M ▼ | 10.431% ▼ | $1.39 ▼ | $215.221M ▲ |
| Q3-2024 | $977.872M | $519.476M | $115.963M | 11.859% | $1.55 | $200.157M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $1.032B ▲ | $6.234B ▲ | $2.276B ▼ | $3.957B ▲ |
| Q2-2025 | $901.157M ▲ | $6.219B ▲ | $2.306B ▼ | $3.913B ▲ |
| Q1-2025 | $873.012M ▼ | $6.103B ▼ | $2.309B ▼ | $3.794B ▼ |
| Q4-2024 | $1.044B ▲ | $6.215B ▼ | $2.363B ▼ | $3.852B ▼ |
| Q3-2024 | $1.042B | $6.366B | $2.422B | $3.944B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $56.753M ▲ | $188.72M ▲ | $-19.761M ▲ | $-64.119M ▲ | $103.466M ▲ | $122.191M ▼ |
| Q2-2025 | $-93.23M ▼ | $128.65M ▲ | $-31.479M ▼ | $-96.299M ▲ | $28.268M ▲ | $153.939M ▲ |
| Q1-2025 | $93.23M ▼ | $52.676M ▼ | $-25.289M ▲ | $-206.756M ▼ | $-170.889M ▼ | $27.387M ▼ |
| Q4-2024 | $103.807M ▼ | $286.078M ▲ | $-53.916M ▼ | $-203.019M ▼ | $1.982M ▼ | $263.117M ▲ |
| Q3-2024 | $115.963M | $263.662M | $-8.919M | $10.572M | $280.519M | $233.862M |
Revenue by Products
| Product | Q1-2024 | Q2-2024 | Q3-2024 | Q4-2024 |
|---|---|---|---|---|
Clear Aligner | $820.00M ▲ | $830.00M ▲ | $790.00M ▼ | $790.00M ▲ |
Scanners And Services | $180.00M ▲ | $200.00M ▲ | $190.00M ▼ | $200.00M ▲ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Align Technology combines a strong, differentiated product platform with solid financial foundations. Revenue and operating profits are growing at a steady, not explosive, pace, underpinned by healthy margins. The balance sheet is conservative, with ample cash and minimal debt, and cash generation is robust enough to fund ongoing investments without relying heavily on external financing. Strategically, Align enjoys a powerful brand, entrenched relationships with dental professionals, and a tightly integrated digital workflow that reinforces customer loyalty. Its innovation engine—spanning materials, software, AI, and 3D printing—supports its leadership in clear aligners and digital dentistry. Key uncertainties include rising competition, pricing pressure, consumer sensitivity to economic conditions, and the need to keep innovating to maintain its technological edge. Overall, Align appears to be a financially sound, innovation‑driven leader in a niche of healthcare that still has room to digitize and expand, but its long‑term trajectory will depend on how well it manages competition and continues to evolve its technology and ecosystem.
NEWS
November 25, 2025 · 7:02 PM UTC
Align Technology Recognized for the 3rd Time in Extel's 2025 All-America Executive Team Rankings, Including the Most Honored Company Distinction
Read more
November 24, 2025 · 8:00 PM UTC
Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction
Read more
November 4, 2025 · 4:01 PM UTC
Align Technology to Speak at Upcoming Financial Conferences
Read more
November 3, 2025 · 4:02 PM UTC
Align Technology Opens 2026 Annual Research Program to Advance Orthodontic and Dental Patient Care
Read more
October 29, 2025 · 4:03 PM UTC
Align Technology Announces Third Quarter 2025 Financial Results
Read more

CEO
Joseph M. Hogan
Compensation Summary
(Year 2024)

CEO
Joseph M. Hogan
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A-
Most Recent Analyst Grades

Stifel
Buy

Evercore ISI Group
Outperform

Mizuho
Outperform

Leerink Partners
Outperform

Wells Fargo
Overweight

Piper Sandler
Overweight

Morgan Stanley
Equal Weight

UBS
Neutral

Jefferies
Hold

Needham
Hold

HSBC
Hold
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
8.302M Shares
$1.222B

BLACKROCK INC.
7.954M Shares
$1.171B

BLACKROCK, INC.
4.954M Shares
$729.214M

CAPITAL INTERNATIONAL INVESTORS
3.05M Shares
$448.984M

BLACKROCK FUND ADVISORS
2.971M Shares
$437.356M

STATE STREET CORP
2.888M Shares
$425.125M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
2.349M Shares
$345.722M

NINETY ONE UK LTD
2.267M Shares
$333.708M

T. ROWE PRICE INVESTMENT MANAGEMENT, INC.
2.256M Shares
$332.116M

WELLINGTON MANAGEMENT GROUP LLP
1.85M Shares
$272.271M

GEODE CAPITAL MANAGEMENT, LLC
1.804M Shares
$265.532M

INVESCO LTD.
1.498M Shares
$220.422M

HOLOCENE ADVISORS, LP
1.43M Shares
$210.447M

BANK OF AMERICA CORP /DE/
1.353M Shares
$199.166M

CAPITAL WORLD INVESTORS
1.317M Shares
$193.829M

JPMORGAN CHASE & CO
1.079M Shares
$158.886M

NUVEEN ASSET MANAGEMENT, LLC
1.013M Shares
$149.13M

MORGAN STANLEY
902.568K Shares
$132.849M

FMR LLC
844.837K Shares
$124.352M

APEX CAPITAL MANAGEMENT
831.293K Shares
$122.358M
Summary
Only Showing The Top 20




